pfizer20.com
Open in
urlscan Pro
2606:4700:3032::ac43:914f
Public Scan
Submitted URL: http://pfizer20.com/
Effective URL: https://pfizer20.com/
Submission: On June 01 via manual — Scanned from DE
Effective URL: https://pfizer20.com/
Submission: On June 01 via manual — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
We're sorry but doesn't work properly without JavaScript enabled. Please enable it to continue. PfizerGlobal PfizerChina Privacy policy Agreement FundProject Recharge Withdraw AppDownload <p>Pfizer China R&D Center is an important R&D hub for Pfizer globally and in the Asia-Pacific region, providing comprehensive support services for global product line development projects. Over the past 30 years, Pfizer has introduced more than 70 products including original drugs and vaccines to the Chinese market. By 2025, Pfizer plans to achieve 24 breakthrough innovative products to apply for listing, and with the gradual implementation of the "80% & 80%" strategic goal, it will try its best to realize the simultaneous application of product research and development in China to meet the health needs of Chinese patients at all stages of life. need.</p> Pfizer-Lorlatinib 0.29% Cycle:1 Hour Initial amount:$5000.00 Invest Pfizer-Talzenna-Talazopanib 2.48% Cycle:7 days Initial amount:$50000.00 Invest Pfizer-Daurismo-Grajib 3.59% Cycle:30 days Initial amount:$100000.00 Invest Pfizer-Lorlatinib-Lorlatinib 3.26% Cycle:90 days Initial amount:$100000.00 Sold out Pfizer-Xalkori-crizotinib 2.55% Cycle:365 days Initial amount:$100000.00 Sold out Pfizer-Aromasin-Exemestane 1.89% Cycle:60 days Initial amount:$10000.00 Sold out Pfizer-Vizimpro-Dacomitinib 2.03% Cycle:180 days Initial amount:$10000.00 Sold out Pfizer-Vitrakvi-Larotrectinib 4.51% Cycle:365 days Initial amount:$100000.00 Sold out POPULAR CONSIDERABLE REVENUEMORE Home Service News Account 请先设置钱包余额支付密码！ 立即设置